Intranuclear SDC-1 has been detected in the setting of multiple myeloma (Stewart et al., 2015), prostate cancer (Farfán et al., 2020) and mesothelioma (Kumar-Singh et al., 2020). The gene discussed is SDC1; the disease is prostate carcinoma.